Procter & Gamble Hygiene and Health Care · NSE: PGHH · BSE: 500459
Q3 FY22 results · Oct–Dec 2021
Procter & Gamble Hygiene and Health Care reported revenue from operations of ₹1,092.98 crore (up 7.3% from Q3 FY21) and net profit of ₹212.06 crore (down 15.4% from Q3 FY21) for Q3 FY22 (Oct–Dec 2021), on a standalone basis.
| Item | Q3 FY22 | Q3 FY21 | YoY | Q2 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,092.98 | 1,018.44 | +7.3% | 1,058.30 | +3.3% |
| Other income | 6.86 | 9.35 | −26.6% | 5.80 | +18.3% |
| Total income | 1,099.84 | 1,027.79 | +7.0% | 1,064.10 | +3.4% |
| Profit before tax | 287.50 | 337.71 | −14.9% | 293.84 | −2.2% |
| Net profit for the period | 212.06 | 250.62 | −15.4% | 218.29 | −2.9% |
| EPS, basic (₹) | 65.33 | 77.21 | −15.4% | 67.25 | −2.9% |
| Net margin (%) | 19.4 | 24.6 | 20.6 |
Standalone
- Filed with BSE
- 01 Feb 2022, 18:06 IST
- Board meeting
- 01 Feb 2022
- Period
- 01 Oct 2021 to 31 Dec 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE